Marty, Caroline
Chaligne, Ronan
Lacout, Catherine
Constantinescu, Stefan N.
[UCL]
Vainchenker, William
Villeval, Jean-Luc
The activating W515L mutation in the thrombopoietin receptor (MPL) has been identified in primary myelofibrosis and essential thrombocythemia. MPL belongs to a subset of the cytokine receptor superfamily that requires the JAK2 kinase for signaling. We examined whether the ligand-independent MPLW515L mutant could signal intracellularly. Addition of the endoplasmic reticulum (ER) retention KDEL sequence to the receptor C terminus efficiently locked MPLW515L within its natural ER/Golgi maturation pathway. In contrast to cells expressing the parental MPLW515L, MPLW515L-KDEL-expressing FDC-P1 cells were unable to grow autonomously and to produce tumors in nude mice. When observed, tumor nodules resulted from in vivo selection of cells leaking the receptor at their surface. JAK2 co-immunoprecipitated with MPLW515L-KDEL but was not phosphorylated. We generated disulfide-bonded MPLW515L homodimers by the S402C substitution, both in the normal and KDEL context. Unlike MPLW515L-KDEL, MPLW515L-S402C-KDEL signaled constitutively and exhibited cell surface localization. These data establish that MPLW515L with appended JAK2 matures through the ER/Golgi system in an inactive conformation and suggest that the MPLW515L/JAK2 complex requires membrane localization for JAK2 phosphorylation, resulting in autonomous receptor signaling.
- J. Leukocyte Biol., 57, 719 (1995)
- Huang Lily Jun-shen, Constantinescu Stefan N., Lodish Harvey F., The N-Terminal Domain of Janus Kinase 2 Is Required for Golgi Processing and Cell Surface Expression of Erythropoietin Receptor, 10.1016/s1097-2765(01)00401-4
- Gent J., van Kerkhof P., Roza M., Bu G., Strous G. J., Ligand-independent growth hormone receptor dimerization occurs in the endoplasmic reticulum and is required for ubiquitin system-dependent endocytosis, 10.1073/pnas.152294299
- Livnah O., Stura E. A., Middleton S. A., Johnson D. L., Jolliffe L. K., Wilson I. A., Crystallographic Evidence for Preformed Dimers of Erythropoietin Receptor Before Ligand Activation, 10.1126/science.283.5404.987
- Kuter D. J., New thrombopoietic growth factors, 10.1182/blood-2006-10-019315
- Otto K. G., Membrane localization is not required for Mpl function in normal hematopoietic cells, 10.1182/blood.v98.7.2077
- Beer P. A., Campbell P. J., Scott L. M., Bench A. J., Erber W. N., Bareford D., Wilkins B. S., Reilly J. T., Hasselbalch H. C., Bowman R., Wheatley K., Buck G., Harrison C. N., Green A. R., MPL mutations in myeloproliferative disorders: analysis of the PT-1 cohort, 10.1182/blood-2008-01-131664
- Chaligne R., James C., Tonetti C., Besancenot R., Le Couedic J. P., Fava F., Mazurier F., Godin I., Maloum K., Larbret F., Lecluse Y., Vainchenker W., Giraudier S., Evidence for MPL W515L/K mutations in hematopoietic stem cells in primitive myelofibrosis, 10.1182/blood-2007-05-089003
- Pardanani A. D., Levine R. L., Lasho T., Pikman Y., Mesa R. A., Wadleigh M., Steensma D. P., Elliott M. A., Wolanskyj A. P., Hogan W. J., McClure R. F., Litzow M. R., Gilliland D. G., Tefferi A., MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients, 10.1182/blood-2006-04-018879
- Pikman Yana, Lee Benjamin H, Mercher Thomas, McDowell Elizabeth, Ebert Benjamin L, Gozo Maricel, Cuker Adam, Wernig Gerlinde, Moore Sandra, Galinsky Ilene, DeAngelo Daniel J, Clark Jennifer J, Lee Stephanie J, Golub Todd R, Wadleigh Martha, Gilliland D. Gary, Levine Ross L, MPLW515L Is a Novel Somatic Activating Mutation in Myelofibrosis with Myeloid Metaplasia, 10.1371/journal.pmed.0030270
- Staerk J., An amphipathic motif at the transmembrane-cytoplasmic junction prevents autonomous activation of the thrombopoietin receptor, 10.1182/blood-2005-06-2600
- Gurney A., Carver-Moore K, de Sauvage F., Moore M., Thrombocytopenia in c-mpl-deficient mice, 10.1126/science.8073287
- Bejcek B., Li D., Deuel T., Transformation by v-sis occurs by an internal autoactivation mechanism, 10.1126/science.2551043
- Santos S. C. R., Internal and external autocrine VEGF/KDR loops regulate survival of subsets of acute leukemia through distinct signaling pathways, 10.1182/blood-2003-05-1634
- Lacout C., JAK2V617F expression in murine hematopoietic cells leads to MPD mimicking human PV with secondary myelofibrosis, 10.1182/blood-2006-02-002030
- Blood, 94, 2555 (1999)
- Vigon I., Mornon J. P., Cocault L., Mitjavila M. T., Tambourin P., Gisselbrecht S., Souyri M., Molecular cloning and characterization of MPL, the human homolog of the v-mpl oncogene: identification of a member of the hematopoietic growth factor receptor superfamily., 10.1073/pnas.89.12.5640
- EMBO J., 14, 5569 (1995)
- Constantinescu S. N., Keren T., Socolovsky M., Nam H.-s., Henis Y. I., Lodish H. F., Ligand-independent oligomerization of cell-surface erythropoietin receptor is mediated by the transmembrane domain, 10.1073/pnas.081069198
- Constantinescu Stefan N, Huang Lily Jun-shen, Nam Hyung-song, Lodish Harvey F, The Erythropoietin Receptor Cytosolic Juxtamembrane Domain Contains an Essential, Precisely Oriented, Hydrophobic Motif, 10.1016/s1097-2765(01)00185-x
- D'Andrea A D, Zon L I, Erythropoietin receptor. Subunit structure and activation., 10.1172/jci114763
- Miesenbock G., The capacity to retrieve escaped ER proteins extends to the trans-most cisterna of the Golgi stack, 10.1083/jcb.129.2.309
- Kaushansky Kenneth, Lok Si, Holly Richard D., Broudy Virginia C., Lin Nancy, Bailey Mason C., Forstrom John W., Buddle Michele M., Oort Pieter J., Hagen Fredrick S., Roth Gerald J., Papayannopoulou Thalia, Foster Donald C., Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin, 10.1038/369568a0
- Jacobson K, Sheets E., Simson R, Revisiting the fluid mosaic model of membranes, 10.1126/science.7770769
- Brown Deborah A., London Erwin, Structure and Function of Sphingolipid- and Cholesterol-rich Membrane Rafts, 10.1074/jbc.r000005200
- Watowich S. S., Yoshimura A., Longmore G. D., Hilton D. J., Yoshimura Y., Lodish H. F., Homodimerization and constitutive activation of the erythropoietin receptor., 10.1073/pnas.89.6.2140
- Yoshimura Akihiko, Longmore Gregory, Lodish Harvey F., Point mutation in the exoplasmic domain of the erythropoietin receptor resulting in hormone-independent activation and tumorigenicity, 10.1038/348647a0
- Blood, 96, 771 (2000)
- Thromb. Haemostasis, 74, 526 (1995)
- Haematologica, 84, 158 (1999)
- Cosman David, Lyman Stewart D., Idzerda Rejean L., Beckmann M.Patricia, Park Linda S., Goodwin Raymond G., March Carl J., A new cytokine receptor superfamily, 10.1016/0968-0004(90)90051-c
- Parganas Evan, Wang Demin, Stravopodis Dimitrios, Topham David J, Marine Jean-Christophe, Teglund Stephan, Vanin Elio F, Bodner Sara, Colamonici Oscar R, van Deursen Jan M, Grosveld Gerard, Ihle James N, Jak2 Is Essential for Signaling through a Variety of Cytokine Receptors, 10.1016/s0092-8674(00)81167-8
- Yamaoka Kunihiro, Saharinen Pipsa, Pesu Marko, Holt Vance ET, Silvennoinen Olli, O'Shea John J, 10.1186/gb-2004-5-12-253
- Royer Yohan, Staerk Judith, Costuleanu Marcel, Courtoy Pierre J., Constantinescu Stefan N., Janus Kinases Affect Thrombopoietin Receptor Cell Surface Localization and Stability, 10.1074/jbc.m501376200
Bibliographic reference |
Marty, Caroline ; Chaligne, Ronan ; Lacout, Catherine ; Constantinescu, Stefan N. ; Vainchenker, William ; et. al. Ligand-independent Thrombopoietin Mutant Receptor Requires Cell Surface Localization for Endogenous Activity. In: Journal of Biological Chemistry, Vol. 284, no. 18, p. 11781-11791 (2009) |
Permanent URL |
http://hdl.handle.net/2078.1/35639 |